BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 22996692)

  • 1. Mutant huntingtin fragmentation in immune cells tracks Huntington's disease progression.
    Weiss A; Träger U; Wild EJ; Grueninger S; Farmer R; Landles C; Scahill RI; Lahiri N; Haider S; Macdonald D; Frost C; Bates GP; Bilbe G; Kuhn R; Andre R; Tabrizi SJ
    J Clin Invest; 2012 Oct; 122(10):3731-6. PubMed ID: 22996692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time-resolved FRET screening identifies small molecular modifiers of mutant Huntingtin conformational inflexibility in patient-derived cells.
    Wilbertz JH; Frappier J; Muller S; Gratzer S; Englaro W; Stanek LM; Calamini B
    SLAS Discov; 2022 Jun; 27(4):219-228. PubMed ID: 35058188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of huntingtin protein species in Huntington's disease patient leukocytes using optimised electrochemiluminescence immunoassays.
    Hensman Moss DJ; Robertson N; Farmer R; Scahill RI; Haider S; Tessari MA; Flynn G; Fischer DF; Wild EJ; Macdonald D; Tabrizi SJ
    PLoS One; 2017; 12(12):e0189891. PubMed ID: 29272284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of mutant huntingtin protein in cerebrospinal fluid from Huntington's disease patients.
    Wild EJ; Boggio R; Langbehn D; Robertson N; Haider S; Miller JR; Zetterberg H; Leavitt BR; Kuhn R; Tabrizi SJ; Macdonald D; Weiss A
    J Clin Invest; 2015 May; 125(5):1979-86. PubMed ID: 25844897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutant Huntingtin Is Cleared from the Brain via Active Mechanisms in Huntington Disease.
    Caron NS; Banos R; Yanick C; Aly AE; Byrne LM; Smith ED; Xie Y; Smith SEP; Potluri N; Findlay Black H; Casal L; Ko S; Cheung D; Kim H; Seong IS; Wild EJ; Song JJ; Hayden MR; Southwell AL
    J Neurosci; 2021 Jan; 41(4):780-796. PubMed ID: 33310753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of mutant huntingtin and neurofilament proteins as potential markers in Huntington's disease.
    Byrne LM; Rodrigues FB; Johnson EB; Wijeratne PA; De Vita E; Alexander DC; Palermo G; Czech C; Schobel S; Scahill RI; Heslegrave A; Zetterberg H; Wild EJ
    Sci Transl Med; 2018 Sep; 10(458):. PubMed ID: 30209243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel human embryonic stem cell-derived Huntington's disease neuronal model exhibits mutant huntingtin (mHTT) aggregates and soluble mHTT-dependent neurodegeneration.
    Lu B; Palacino J
    FASEB J; 2013 May; 27(5):1820-9. PubMed ID: 23325320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small molecule modulator of protein disulfide isomerase attenuates mutant huntingtin toxicity and inhibits endoplasmic reticulum stress in a mouse model of Huntington's disease.
    Zhou X; Li G; Kaplan A; Gaschler MM; Zhang X; Hou Z; Jiang M; Zott R; Cremers S; Stockwell BR; Duan W
    Hum Mol Genet; 2018 May; 27(9):1545-1555. PubMed ID: 29462355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TR-FRET-based duplex immunoassay reveals an inverse correlation of soluble and aggregated mutant huntingtin in huntington's disease.
    Baldo B; Paganetti P; Grueninger S; Marcellin D; Kaltenbach LS; Lo DC; Semmelroth M; Zivanovic A; Abramowski D; Smith D; Lotz GP; Bates GP; Weiss A
    Chem Biol; 2012 Feb; 19(2):264-75. PubMed ID: 22365609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salivary Huntingtin protein is uniquely associated with clinical features of Huntington's disease.
    Parkin GM; Corey-Bloom J; Snell C; Smith H; Laurenza A; Daldin M; Bresciani A; Thomas EA
    Sci Rep; 2023 Jan; 13(1):1034. PubMed ID: 36658243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Huntingtin Co-Isolates with Small Extracellular Vesicles from Blood Plasma of TgHD and KI-HD Pig Models of Huntington's Disease and Human Blood Plasma.
    Ananbeh H; Novak J; Juhas S; Juhasova J; Klempir J; Doleckova K; Rysankova I; Turnovcova K; Hanus J; Hansikova H; Vodicka P; Kupcova Skalnikova H
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of an ELISA assay for the quantification of soluble huntingtin in human blood cells.
    Massai L; Petricca L; Magnoni L; Rovetini L; Haider S; Andre R; Tabrizi SJ; Süssmuth SD; Landwehrmeyer BG; Caricasole A; Pollio G; Bernocco S
    BMC Biochem; 2013 Nov; 14():34. PubMed ID: 24274906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serine 421 regulates mutant huntingtin toxicity and clearance in mice.
    Kratter IH; Zahed H; Lau A; Tsvetkov AS; Daub AC; Weiberth KF; Gu X; Saudou F; Humbert S; Yang XW; Osmand A; Steffan JS; Masliah E; Finkbeiner S
    J Clin Invest; 2016 Sep; 126(9):3585-97. PubMed ID: 27525439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic manipulations of mutant huntingtin in mice: new insights into Huntington's disease pathogenesis.
    Lee CY; Cantle JP; Yang XW
    FEBS J; 2013 Sep; 280(18):4382-94. PubMed ID: 23829302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fragments of HdhQ150 mutant huntingtin form a soluble oligomer pool that declines with aggregate deposition upon aging.
    Marcellin D; Abramowski D; Young D; Richter J; Weiss A; Marcel A; Maassen J; Kauffmann M; Bibel M; Shimshek DR; Faull RL; Bates GP; Kuhn RR; Van der Putten PH; Schmid P; Lotz GP
    PLoS One; 2012; 7(9):e44457. PubMed ID: 22984513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Huntingtin silencing delays onset and slows progression of Huntington's disease: a biomarker study.
    Liu H; Zhang C; Xu J; Jin J; Cheng L; Miao X; Wu Q; Wei Z; Liu P; Lu H; van Zijl PCM; Ross CA; Hua J; Duan W
    Brain; 2021 Nov; 144(10):3101-3113. PubMed ID: 34043007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrajugular vein delivery of AAV9-RNAi prevents neuropathological changes and weight loss in Huntington's disease mice.
    Dufour BD; Smith CA; Clark RL; Walker TR; McBride JL
    Mol Ther; 2014 Apr; 22(4):797-810. PubMed ID: 24390280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid mutant huntingtin is a biomarker for huntingtin lowering in the striatum of Huntington disease mice.
    Caron NS; Banos R; Aly AE; Xie Y; Ko S; Potluri N; Anderson C; Black HF; Anderson LM; Gordon B; Southwell AL; Hayden MR
    Neurobiol Dis; 2022 May; 166():105652. PubMed ID: 35143966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of mutant and total huntingtin expression in Huntington's disease murine models.
    Fodale V; Pintauro R; Daldin M; Altobelli R; Spiezia MC; Bisbocci M; Macdonald D; Bresciani A
    Sci Rep; 2020 Dec; 10(1):22137. PubMed ID: 33335120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rescue of aberrant huntingtin palmitoylation ameliorates mutant huntingtin-induced toxicity.
    Lemarié FL; Caron NS; Sanders SS; Schmidt ME; Nguyen YTN; Ko S; Xu X; Pouladi MA; Martin DDO; Hayden MR
    Neurobiol Dis; 2021 Oct; 158():105479. PubMed ID: 34390831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.